Hematology and Blood Disorders

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Diffuse Large B Cell Lymphoma and Clinical Intervention

2nd International Conference on Hematology and Oncology
August 23-24, 2018 | London, UK

Ashok Srivastava

Clinfomatrix Oncology, USA

Posters & Accepted Abstracts : Hematol Blood Disord

Abstract:

Diffuse large B-cell lymphoma: It is the most common type of non-Hodgkin lymphoma among adults. Diffuse large B-cell lymphoma occurs primarily in older individuals, with a median age of diagnosis at approximately 65-70 years of age, though it can also occur in children and young adults in rare cases. Diffuse large B-cell lymphoma is an aggressive tumor, sometimes associated with fever, weight loss, and night sweats. The cause of diffuse large B-cell lymphoma is not well understood. Typically, diffuse large B-cell lymphoma arises from normal B cells, but it can also represent a malignant transformation of other types of lymphoma or leukemia. However, the usual treatment of these is chemotherapy, often in combination with an antibody targeted at the tumor cells. However, survival rate of patients varies. The details of the clinical data will be presented.

Biography:

E-mail:

ashok.srivastava@curepharmaceuticaslinc.com

PDF HTML
Get the App